{"id":"92daa312-c3af-5d2c-9f10-ddfe604171db","stable_key":"182336c6-ed36-5ec6-8a09-25c31096262e:dim-olanzapine-fmo","predicate":"forms_from_olanzapine","statement":"FMO3 played a major role in olanzapine N-oxide formation.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"2aa5feaa-46ea-5c28-82c4-234b9e4fc9cc","mechanism_event_label":"This independently identified route also contributes to olanzapine handling.","subject":{"id":"2adc7121-010a-5cfb-b97c-5873c88a350a","slug":"fmo3","display_name":"Human flavin-containing monooxygenase 3","entity_type_key":"protein"},"object":{"id":"9f654206-eba9-5773-8bbf-0605f939d8d7","slug":"olanzapine-n-oxide","display_name":"Olanzapine N-oxide","entity_type_key":"small_molecule"},"evidence_count":1,"mechanism_event":{"id":"2aa5feaa-46ea-5c28-82c4-234b9e4fc9cc","stable_key":"182336c6-ed36-5ec6-8a09-25c31096262e:dim-olanzapine-fmo-event","event_type":"biochemical_relationship","label":"This independently identified route also contributes to olanzapine handling.","description":"FMO3 played a major role in olanzapine N-oxide formation.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"e83902e5-cd44-5de2-b790-abf19033d265","slug":"olanzapine","display_name":"Olanzapine","entity_type_key":"small_molecule"},"role":"substrate","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"2adc7121-010a-5cfb-b97c-5873c88a350a","slug":"fmo3","display_name":"Human flavin-containing monooxygenase 3","entity_type_key":"protein"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"9f654206-eba9-5773-8bbf-0605f939d8d7","slug":"olanzapine-n-oxide","display_name":"Olanzapine N-oxide","entity_type_key":"small_molecule"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/dim-research/26329789.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"1f2f35be434034ef4788653d084a6b184b1b5a109d445591c4fd0fc94b36e543\", \"start_char\": 0, \"end_char\": 1657, \"text_sha256\": \"1f2f35be434034ef4788653d084a6b184b1b5a109d445591c4fd0fc94b36e543\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human liver microsomes and recombinant enzyme phenotyping","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Metabolite-specific assays including albumin effects","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"In-vitro relative contributions; no DIM coadministration. Multiple routes limit prediction from CYP1A2 alone.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"dim","display_name":"3,3'-Diindolylmethane / DIM","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human CYP, FMO and UGT enzymes","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"This independently identified route also contributes to olanzapine handling.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[dim-p26329789] In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine Metabolism. (2015). https://pubmed.ncbi.nlm.nih.gov/26329789/ DOI: 10.1124/dmd.115.064790","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Olanzapine oxidation and conjugation","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"c3229e75-80d4-5c62-98c0-a947aa89f5b5","evidence_kind":"source_excerpt","locator":"Lines 727-738","start_line":727,"end_line":738,"excerpt":"### dim-olanzapine-fmo\nFMO3 played a major role in olanzapine N-oxide formation.\nCondition category: normal\nnutrient_topic: Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: This independently identified route also contributes to olanzapine handling.\norganism: Human CYP, FMO and UGT enzymes\ntissue_or_cell_type: Olanzapine oxidation and conjugation\nexperimental_model: Human liver microsomes and recombinant enzyme phenotyping\nlimitations: In-vitro relative contributions; no DIM coadministration. Multiple routes limit prediction from CYP1A2 alone.\nexposure: Metabolite-specific assays including albumin effects\nevidence_span: {\"source_cache\": \"artifacts/dim-research/26329789.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"1f2f35be434034ef4788653d084a6b184b1b5a109d445591c4fd0fc94b36e543\", \"start_char\": 0, \"end_char\": 1657, \"text_sha256\": \"1f2f35be434034ef4788653d084a6b184b1b5a109d445591c4fd0fc94b36e543\"}\n[dim-p26329789] In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine Metabolism. (2015). https://pubmed.ncbi.nlm.nih.gov/26329789/ DOI: 10.1124/dmd.115.064790","model_system":"Human liver microsomes and recombinant enzyme phenotyping","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [dim-p26329789] In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine Metabolism. (2015). https://pubmed.ncbi.nlm.nih.gov/26329789/ DOI: 10.1124/dmd.115.064790","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"b6d70682-97f9-5893-a03c-f9f88836033c","stable_key":"import-182336c6-ed36-5ec6-8a09-25c31096262e","title":"Diindolylmethane (DIM): formation, receptor signaling, metabolism and drug interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"31e14060de904976d2f5d439f2bc9c8a99a72d34626c562c78429025e050d404","revision_id":"611094c1-a9cf-5b9b-b255-ac70b571696a","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}